159 related articles for article (PubMed ID: 10993221)
21. Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: establishment of a new highly sensitive simultaneous androgen measurement method.
Kashiwagi B; Shibata Y; Ono Y; Suzuki R; Honma S; Suzuki K
J Androl; 2005; 26(5):586-91. PubMed ID: 16088034
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of steroid 5 alpha-reductase in vivo: effect on suppression of luteinizing hormone and stimulation of accessory sex organs by testosterone in the orchidectomized rat.
Kao LW; Weisz J
J Endocrinol; 1979 May; 81(2):209-20. PubMed ID: 458345
[TBL] [Abstract][Full Text] [Related]
23. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758).
Neubauer BL; Biser P; Jones CD; Mariotti A; Hoover DM; Thornton T; Thornton MO; Goode RL
Prostate; 1989; 15(3):273-86. PubMed ID: 2531383
[TBL] [Abstract][Full Text] [Related]
25. Prolactin influences upon androgen action in male accessory sex organs.
Thomas JA; Keenan EJ
Adv Sex Horm Res; 1976; 2():425-70. PubMed ID: 189591
[TBL] [Abstract][Full Text] [Related]
26. Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase.
Bratoeff E; Sainz T; Cabeza M; Heuze I; Recillas S; Pérez V; Rodríguez C; Segura T; Gonzáles J; Ramírez E
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):48-56. PubMed ID: 17629476
[TBL] [Abstract][Full Text] [Related]
27. Activity of steroid 4 and derivatives 4a-4f as inhibitors of the enzyme 5α-reductase 1.
Arellano Y; Bratoeff E; Heuze Y; Bravo M; Soriano J; Cabeza M
Bioorg Med Chem; 2018 Aug; 26(14):4058-4064. PubMed ID: 30007568
[TBL] [Abstract][Full Text] [Related]
28. Steroid 5alpha-reductase inhibitors.
Flores E; Bratoeff E; Cabeza M; Ramirez E; Quiroz A; Heuze I
Mini Rev Med Chem; 2003 May; 3(3):225-37. PubMed ID: 12570838
[TBL] [Abstract][Full Text] [Related]
29. Demonstration and partial characterization of cytosol receptors for testosterone.
Gustafasson J; Pousette K
Biochemistry; 1975 Jul; 14(14):3094-101. PubMed ID: 167816
[TBL] [Abstract][Full Text] [Related]
30. Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG).
Labrie F; Luu-The V; Martel C; Chernomoretz A; Calvo E; Morissette J; Labrie C
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):52-8. PubMed ID: 16797178
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
32. Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice.
Skarda J
J Vet Med A Physiol Pathol Clin Med; 2003 May; 50(4):204-12. PubMed ID: 12948158
[TBL] [Abstract][Full Text] [Related]
33. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.
Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J
Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and pharmacological effect of 6-halo-16 beta-methyl-pregnane derivatives.
Cabeza M; Gutiérrez E; Miranda R; Heuze I; Bratoeff E; Flores G; Ramírez E
Proc West Pharmacol Soc; 1998; 41():87-8. PubMed ID: 9836254
[No Abstract] [Full Text] [Related]
35. Antiandrogenic effects of topically applied spironolactone on the hamster flank organ.
Weissmann A; Bowden J; Frank BL; Horwitz SN; Frost P
Arch Dermatol; 1985 Jan; 121(1):57-62. PubMed ID: 3155605
[TBL] [Abstract][Full Text] [Related]
36. Binding of androgens in 5 alpha-reductase-deficient human genital skin fibroblasts: inhibition by progesterone and its metabolites.
Hodgins MB
J Endocrinol; 1982 Sep; 94(3):415-27. PubMed ID: 7119651
[TBL] [Abstract][Full Text] [Related]
37. Aromatic esters of progesterone as 5alpha-reductase and prostate growth inhibitors.
Bratoeff E; Segura T; Recillas S; Carrizales E; Palacios A; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):655-62. PubMed ID: 18825535
[TBL] [Abstract][Full Text] [Related]
38. Antiandrogenic activity of a series of des-A-steroid derivatives.
Morales-Alanis H; Brienne MJ; Jacques J; Bouton MM; Nédélec L; Torelli V; Tournemine C
J Med Chem; 1985 Dec; 28(12):1796-803. PubMed ID: 4068004
[TBL] [Abstract][Full Text] [Related]
39. 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E; Flores E
Proc West Pharmacol Soc; 2002; 45():164-5. PubMed ID: 12434569
[TBL] [Abstract][Full Text] [Related]
40. Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.
Bratoeff E; García P; Heuze Y; Soriano J; Mejía A; Labastida AM; Valencia N; Cabeza M
Steroids; 2010 Jul; 75(7):499-505. PubMed ID: 20359488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
